The Law Firm Of Weiss & Lurie Investigates The Proposed Buyout Of Caraco Pharmaceuticals Laboratories Ltd.
Weiss & Lurie, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating potential claims against members of the Board of Directors of Caraco Pharmaceuticals Laboratories Ltd. (AMEX: CPD), Sun Pharmaceuticals Laboratories Ltd. and Sun Pharma Global, Inc. (“Sun Pharma”), arising from Caraco’s receipt of a proposal by Sun Pharma and/or one or more of their affiliates to acquire the remainder of Caraco shares not already owned by Sun Pharma, in a potential transaction offering Caraco public shareholders $4.75 in cash for each share of Caraco stock they hold. In response to the proposal, Caraco shares closed at $5.13 per share on December 6, 2010. Caraco shares were trading as high as $6.66 as of August 9, 2010.
Weiss & Lurie is investigating whether Caraco’s Board is acting in the best interests of its public shareholders in seeking to maximize shareholder value by adequately shopping Caraco and whether the sales process is unfair to Caraco public shareholders in light of the fact that Sun Pharma already owns approximately 75.8% of Caraco’s outstanding shares.
If you own common stock in Caraco and would like more information about your rights as a shareholder or additional information concerning our investigation, please contact Michael A. Rogovin either by email at firstname.lastname@example.org or by telephone at (888) 593-4771. Weiss & Lurie has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded institutions and individuals and obtained important corporate governance in these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (such as insider trading, waste of corporate assets, accounting fraud, or issuing materially misleading press releases or SEC filings), consumer fraud (such as false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at email@example.com or fill out the form on our website, http://www.weisslurie.com/contact/report_fraud/.
Attorney Advertising. Past results do not guarantee a similar outcome.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV